Total Payments
$630.43
2024 Payments
$265.18
Companies
15
Transactions
17
Medicare Patients
2,161
Medicare Billing
$243,397
Payment Breakdown by Category
Food & Beverage$630.43 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $630.43 | 17 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Boston Scientific Corporation | $144.89 | 2 | $0 (2024) |
| IDORSIA PHARMACEUTICALS US INC | $125.00 | 1 | $0 (2023) |
| GENZYME CORPORATION | $120.29 | 1 | $0 (2024) |
| Myriad Women's Health, Inc. | $61.32 | 1 | $0 (2023) |
| AbbVie Inc. | $27.94 | 2 | $0 (2021) |
| Allergan Inc. | $23.94 | 1 | $0 (2017) |
| Myovant Sciences Inc. | $17.01 | 1 | $0 (2022) |
| Hologic, LLC | $15.82 | 1 | $0 (2018) |
| Exeltis, USA Inc. | $14.90 | 1 | $0 (2022) |
| MAYNE PHARMA INC. | $14.83 | 1 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $265.18 | 3 | Boston Scientific Corporation ($144.89) |
| 2023 | $186.32 | 2 | IDORSIA PHARMACEUTICALS US INC ($125.00) |
| 2022 | $85.78 | 6 | Myovant Sciences Inc. ($17.01) |
| 2021 | $27.77 | 2 | MAYNE PHARMA INC. ($14.83) |
| 2019 | $15.00 | 1 | AbbVie, Inc. ($15.00) |
| 2018 | $26.44 | 2 | Hologic, LLC ($15.82) |
| 2017 | $23.94 | 1 | Allergan Inc. ($23.94) |
All Payment Transactions
17 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/11/2024 | Boston Scientific Corporation | — | Food and Beverage | In-kind items and services | $127.82 | General |
| 12/11/2024 | Boston Scientific Corporation | — | Food and Beverage | In-kind items and services | $17.07 | General |
| 03/05/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $120.29 | General |
| Category: Immunology | ||||||
| 12/07/2023 | Myriad Women's Health, Inc. | MYRISK (Device) | Food and Beverage | In-kind items and services | $61.32 | General |
| Category: ONCOLOGY | ||||||
| 04/19/2023 | IDORSIA PHARMACEUTICALS US INC | QUVIVIQ (Drug) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: INSOMNIA | ||||||
| 06/17/2022 | Exeltis, USA Inc. | SLYND (Drug) | Food and Beverage | In-kind items and services | $14.90 | General |
| Category: Oral Contraceptive | ||||||
| 04/28/2022 | Astellas Pharma US Inc | Myrbetriq (Drug) | Food and Beverage | In-kind items and services | $12.35 | General |
| Category: Urology | ||||||
| 04/15/2022 | Agile Therapeutics, Inc. | Twirla (Drug) | Food and Beverage | In-kind items and services | $13.35 | General |
| Category: Birth Control Contraceptive Patch | ||||||
| 03/25/2022 | Biohaven Pharmaceutical Holding Company Ltd. | NURTEC ODT (Drug) | Food and Beverage | In-kind items and services | $13.89 | General |
| Category: PRIMARY CARE | ||||||
| 03/04/2022 | Myovant Sciences Inc. | MYFEMBREE (Drug) | Food and Beverage | In-kind items and services | $17.01 | General |
| Category: HORMONE THERAPY | ||||||
| 01/13/2022 | Shield Therapeutics Inc | ACCRUFER (Drug) | Food and Beverage | In-kind items and services | $14.28 | General |
| Category: Hematology | ||||||
| 10/08/2021 | MAYNE PHARMA INC. | — | Food and Beverage | In-kind items and services | $14.83 | General |
| 10/01/2021 | AbbVie Inc. | ORIAHNN (Drug), LO LOESTRIN FE | Food and Beverage | In-kind items and services | $12.94 | General |
| Category: WOMENS HEALTH | ||||||
| 05/30/2019 | AbbVie, Inc. | Orilissa (Drug) | Food and Beverage | In-kind items and services | $15.00 | General |
| Category: Endocrinology | ||||||
| 10/03/2018 | PFIZER INC. | PREMARIN (Drug), ESTRING | Food and Beverage | In-kind items and services | $10.62 | General |
| Category: WOMENS HEALTH | ||||||
| 08/30/2018 | Hologic, LLC | HPV (Device) | Food and Beverage | In-kind items and services | $15.82 | General |
| Category: Diagnostics | ||||||
| 02/21/2017 | Allergan Inc. | LILETTA (Drug) | Food and Beverage | In-kind items and services | $23.94 | General |
| Category: WOMENS HEALTH | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 6 | 464 | 600 | $152,740 | $56,241 |
| 2022 | 11 | 588 | 771 | $217,279 | $69,521 |
| 2021 | 11 | 654 | 807 | $348,583 | $73,761 |
| 2020 | 8 | 455 | 546 | $143,492 | $43,875 |
Total Patients
2,161
Total Services
2,724
Medicare Billing
$243,397
Procedure Codes
36
All Medicare Procedures & Services
36 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 158 | 281 | $49,164 | $19,438 | 39.5% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 85 | 85 | $11,953 | $11,714 | 98.0% |
| 76830 | Ultrasound scan of uterus, ovaries, tubes, cervix and pelvic area through vagina | Office | 2023 | 73 | 78 | $15,031 | $8,666 | 57.7% |
| 93976 | Ultrasound of abdomen and pelvis artery and vein blood flow | Office | 2023 | 55 | 58 | $47,350 | $7,644 | 16.1% |
| 76856 | Complete ultrasound scan of pelvis | Office | 2023 | 76 | 81 | $25,135 | $7,400 | 29.4% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 17 | 17 | $4,107 | $1,380 | 33.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 138 | 245 | $57,264 | $17,882 | 31.2% |
| 93976 | Ultrasound of abdomen and pelvis artery and vein blood flow | Office | 2022 | 73 | 89 | $72,150 | $12,339 | 17.1% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 86 | 86 | $14,076 | $11,854 | 84.2% |
| 76830 | Ultrasound scan of uterus, ovaries, tubes, cervix and pelvic area through vagina | Office | 2022 | 77 | 99 | $18,685 | $11,227 | 60.1% |
| 76856 | Complete ultrasound scan of pelvis | Office | 2022 | 80 | 102 | $31,309 | $9,487 | 30.3% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 30 | 30 | $7,745 | $2,788 | 36.0% |
| G0438 | Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | Office | 2022 | 12 | 12 | $2,852 | $1,347 | 47.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 11 | 11 | $2,618 | $1,157 | 44.2% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2022 | 23 | 25 | $8,781 | $1,009 | 11.5% |
| 81025 | Urine pregnancy test | Office | 2022 | 29 | 36 | $900.00 | $307.19 | 34.1% |
| 81002 | Urinalysis, manual test | Office | 2022 | 29 | 36 | $900.00 | $124.21 | 13.8% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 129 | 230 | $57,727 | $17,613 | 30.5% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2021 | 111 | 111 | $40,350 | $15,719 | 39.0% |
| 93976 | Ultrasound limited scan of abdominal, pelvic, and/or scrotal arterial inflow and venous outflow | Office | 2021 | 77 | 86 | $93,050 | $11,911 | 12.8% |
| 76830 | Ultrasound pelvis through vagina | Office | 2021 | 80 | 89 | $57,797 | $10,441 | 18.1% |
| 76856 | Ultrasound of pelvis, complete, not pregnancy related | Office | 2021 | 82 | 91 | $58,468 | $8,831 | 15.1% |
| 99203 | New patient outpatient visit, total time 30-44 minutes | Office | 2021 | 31 | 31 | $11,351 | $3,012 | 26.5% |
| G0438 | Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | Office | 2021 | 24 | 24 | $7,950 | $2,878 | 36.2% |
| 99212 | Established patient outpatient visit, total time 10-19 minutes | Office | 2021 | 38 | 38 | $16,415 | $1,949 | 11.9% |
About Dr. Sarla Zaveri, M.D
Dr. Sarla Zaveri, M.D is a Obstetrics & Gynecology healthcare provider based in West Paterson, New Jersey. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 11/08/2006. The National Provider Identifier (NPI) number assigned to this provider is 1821168774.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Sarla Zaveri, M.D has received a total of $630.43 in payments from pharmaceutical and medical device companies, with $265.18 received in 2024. These payments were reported across 17 transactions from 15 companies. The most common payment nature is "Food and Beverage" ($630.43).
As a Medicare-enrolled provider, Zaveri has provided services to 2,161 Medicare beneficiaries, totaling 2,724 services with total Medicare billing of $243,397. Data is available for 4 years (2020–2023), covering 36 distinct procedure/service records.
Ad
Practice Information
- Specialty Obstetrics & Gynecology
- Location West Paterson, NJ
- Active Since 11/08/2006
- Last Updated 07/08/2007
- Taxonomy Code 207V00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1821168774
Products in Payments
- QUVIVIQ (Drug) $125.00
- DUPIXENT (Biological) $120.29
- MYRISK (Device) $61.32
- LILETTA (Drug) $23.94
- MYFEMBREE (Drug) $17.01
- HPV (Device) $15.82
- Orilissa (Drug) $15.00
- SLYND (Drug) $14.90
- ACCRUFER (Drug) $14.28
- NURTEC ODT (Drug) $13.89
- Twirla (Drug) $13.35
- ORIAHNN (Drug) $12.94
- Myrbetriq (Drug) $12.35
- PREMARIN (Drug) $10.62
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.